Literature DB >> 16920989

Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.

Zoltán Bánki1, Doris Wilflingseder, Christoph G Ammann, Monika Pruenster, Brigitte Müllauer, Karoline Holländer, Martina Meyer, Georg M Sprinzl, Jan van Lunzen, Hans-Jürgen Stellbrink, Manfred P Dierich, Heribert Stoiber.   

Abstract

Our study demonstrates that binding of complement-opsonized HIV to complement receptor type 1 on human erythrocytes (E) via C3b fragments is followed by a rapid normal human serum-mediated detachment of HIV from E. The release was dependent on the presence of factor I indicating a conversion of C3b fragments to iC3b and C3d on the viral surface. This in turn resulted in an efficient binding of opsonized HIV to CR2-expressing B cells, thus facilitating B cell-mediated transmission of HIV to T cells. These data provide a new dynamic view of complement opsonization of HIV, suggesting that association of virus with E might be a transient phenomenon and the factor I-mediated processing of C3b to iC3b and C3d on HIV targets the virus to complement receptor type 2-expressing cells. Thus, factor I in concert with CR1 on E and factor H in serum due to their cofactor activity are likely to be important contributors for the generation of C3d-opsonized infectious HIV reservoirs on follicular dendritic cells and/or B cells in HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920989     DOI: 10.4049/jimmunol.177.5.3469

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination.

Authors:  David C Montefiori; Lynn Morris; Guido Ferrari; John R Mascola
Journal:  Curr Opin HIV AIDS       Date:  2007-05       Impact factor: 4.283

Review 2.  The good and evil of complement activation in HIV-1 infection.

Authors:  Qigui Yu; Richard Yu; Xuebin Qin
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

Review 3.  Follicular dendritic cells: dynamic antigen libraries.

Authors:  Balthasar A Heesters; Riley C Myers; Michael C Carroll
Journal:  Nat Rev Immunol       Date:  2014-06-20       Impact factor: 53.106

4.  Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.

Authors:  Kazi Abdus Salam; Richard Y Wang; Teresa Grandinetti; Valeria De Giorgi; Harvey J Alter; Robert D Allison
Journal:  Hepatology       Date:  2018-11-01       Impact factor: 17.425

5.  HIV-1 fusion inhibitor peptides enfuvirtide and T-1249 interact with erythrocyte and lymphocyte membranes.

Authors:  Pedro M Matos; Miguel A R B Castanho; Nuno C Santos
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

6.  Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

Authors:  Weijing He; Stuart Neil; Hemant Kulkarni; Edward Wright; Brian K Agan; Vincent C Marconi; Matthew J Dolan; Robin A Weiss; Sunil K Ahuja
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

Review 7.  Viruses exploit the tissue physiology of the host to spread in vivo.

Authors:  Xaver Sewald; Nasim Motamedi; Walther Mothes
Journal:  Curr Opin Cell Biol       Date:  2016-05-03       Impact factor: 8.382

8.  A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement.

Authors:  Yuanyong Xu; Chuanfu Zhang; Leili Jia; Cuirong Wen; Huihui Liu; Yong Wang; Yansong Sun; Liuyu Huang; Yusen Zhou; Hongbin Song
Journal:  Virol J       Date:  2009-08-12       Impact factor: 4.099

9.  Presence of IgG anti-gp160/120 antibodies confers higher HIV capture capacity to erythrocytes from HIV-positive individuals.

Authors:  Maria Noé Garcia; Maria Sol dos Ramos Farias; Lucia Fazzi; Daniel Grasso; Roberto Daniel Rabinovich; Maria Mercedes Ávila
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Microglia, Alzheimer's disease, and complement.

Authors:  Helen Crehan; John Hardy; Jennifer Pocock
Journal:  Int J Alzheimers Dis       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.